Bertrand Fourquet founded (2001) and directed Echosens, an innovative medical device company in hepatology. Acquired in June 2011 by the Chinese pharmaceutical group Furui, Echosens employs around 60 people and posts more than 20 million euros in sales.
Prior to that, he created the Spanish subsidiary of the Distriborg group (organic food in supermarkets) and he ran a Spanish company for trading with large retailers. Bertrand Fourquet began his career in mergers and acquisitions at Lazard Frères (New York), then at JP Morgan (London).
He graduated from Essec Business School and holds a degree (L3) in physics.
Engineer in Physics.
After two years of development in optical instrumentation, David Poizat joined Echosens in 2003 to lead the industrialization and manufacturing of the Fibroscan medical device that was beginning to be marketed.
He was quickly assigned more responsibilities and took charge of CE marking and Quality system management, which earned ISO 13485 certification in 2005. Then he also directed the after sales service department.
This portfolio of responsibilities allowed him to acquire serious skills in industrial transfer under quality assurance.
In 2011, he joined the Quattrocento team to coordinate the industrial development of products in each of the subsidiaries.
An Engineer with a PhD in Physics. After his thesis, he created his own company dedicated to scientific expertise and consulting for small businesses. He then joined the ESPCI neurobiology laboratory to commercialize the DNA chip project. He founded and directed GeneScore, a biotech company specialized in DNA chip manufacturing, which he directed until 2005.
In 2005, he became project leader of the CEDIB, a project to create a bioengineering innovation center.
He was also project manager of commercialization services at Paris Diderot University and technological development manager at Echosens.
He has been the General Manager of Quattrocento since 2010.
Professor-Researcher at CNAM and at the University Paris-Dauphine in health economics, Stéphane Billion was successively a Financial and Technical Consultant within a Regional Hospitalization Agency and Head of the Hospitalization Agency for a Social Security fund. In 2007 he created and then directed KAMEDIS Conseil, a research and consulting firm specializing in market access strategy for drugs and medical devices and in medico-economic evaluation.
An Engineer and PhD in bioengineering specialized in high-frequency acoustics, Matteo Bosisio is currently Open Innovation Manager at Kerr Corporation, a Danaher company. Since 2010, he has been director of AEVA SAGL, a consulting firm he founded, specialized in innovation in the field of Life Sciences.
A lawyer by training, Claire Durand-Ruel handled coordination between French political and military authorities and the aeronautics/armament industry for large capital goods sales contracts with Qatar. Claire Durand-Ruel now devotes herself to discovering and promoting the young French contemporary art scene.
François Durand-Ruel has worked for over thirty years in the aeronautics and high technology field. He gained experience in trading, strategic partnerships and international cooperation in Europe, the Middle East, Russia, USA, Asia and the Indian subcontinent. He is also personally passionate about aeronautics and contemporary art.
A freelance designer since 1997, Philippe Fourquet is artistic director of communications projects for companies and institutions in various fields: research, publishing, culture, and multimedia. He designs and develops web interfaces including the visual identities of Quattrocento and its subsidiaries.
Since 1984 Manuel Gallardo has been head of DECLIC, a development company specialized in the implementation of industrial products on behalf of companies in various sectors (mobile phones, printers, weighing terminals and various medical devices for the medical and optics sectors).
Jean-Noël Helal is a ENSEIRB engineer and holds a PhD from the UTC. He is specialized in management and development of digital products and services. He founded and runs the company Bleu SOLID. This company supports projects in science, industry and technology. It offers consulting, control, implementation and industrialization in electronic and computer.
Over the course of his professional career, Thomas Kermorgant has steered businesses through start-up, growth, operational improvement and turnaround situations. He has conducted business in Europe, Africa and India and has been effective in both small and large organizations. As an investor, an advisor and as a manager, Thomas Kermorgant has learnt to create value. Since March 2011, he has been responsible for CoBe Capital’s European business from an M&A and operational perspective. CoBe Capital is a global private investment firm with a permanent capital base which acquires and operates non-core and underperforming business units of large corporates.
Fabrice Richard holds a PhD in chemistry and a Master of Business Administration. He was COO of Genescore, a company that specializes in the field of DNA microarrays. In 2007, he joined the Entrepreneurship Network, an international association of entrepreneurs, to take over responsibility for a program to fund and support entrepreneurs in innovative technological sectors. He is now chief operating officer of Easy Life Science, a subsidiary of Quattrocento.
Laurent Sanchez manages Laurent Sanchez Consultants, a consulting firm specializing in organization, human resources, coaching and negotiation. Since 2003, the firm has specialized in performing outsourced HR services for VSE / SME and advising Management teams.